Misc. news stories

The Colorado psychedelic mushroom experiment has arrived
26th March 2025 abcnews.go.com | Humans, Misc.

Colorado regulators are issuing licenses for providing psychedelic mushrooms and are planning to authorize the state’s first “healing centers,” where the mushrooms can be ingested under supervision, in late spring or early summer.

Can ibogaine repair brain damage in multiple sclerosis? New case reports spark interest
24th March 2025 | psypost.org | Humans, Misc.

In a recent case report published in Frontiers in Immunology, scientists in Canada described how an experimental treatment using a naturally derived substance called ibogaine appeared to improve symptoms and brain health in two individuals with multiple sclerosis.

Ketamine shows promise for treatment-resistant PTSD in psychedelic-style therapy settings
20th March 2025 | psypost.org | Humans, Misc.

A new study published in the Journal of Psychopharmacology suggests that intravenous ketamine, when administered in a setting that mirrors psychedelic-assisted therapy, can lead to substantial and sustained reductions in symptoms of post-traumatic stress disorder (PTSD).

Psilocybin increases emotional empathy in depressed individuals, study finds
3rd March 2025 | psypost.org | Humans, Misc.

A study conducted in Switzerland examined changes in empathy among depressed individuals following a single dose of psilocybin. Participants who received psilocybin demonstrated substantial improvements in emotional empathy compared to the control group, which received a placebo. These improvements lasted for at least two weeks after treatment. The paper was published in Molecular Psychiatry.

Little-known psychedelic drug reduces motivation to take heroin in rats, study finds
4th February 2025 | psypost.org | Humans, Misc.

A study on rats found that administering 2,5-dimethoxy-4-iodoamphetamine before giving them an opportunity to take heroin reduced their motivation to do so…The study also identified a specific type of receptor on neural cells that is crucial for this effect. The paper was published in Neuropharmacology.

Psychedelic drug DMT to be trialled on UK volunteers to tackle alcohol misuse
20th January 2025 | theguardian.com | Humans, Misc.

A powerful psychedelic that is used in healing ceremonies by Indigenous groups in the Amazon is being trialled as a pioneering approach to reduce problematic alcohol consumption.

Experiences of awe may drive ketamine’s antidepressant benefits
13th January 2025 | psypost.org | Humans, Misc.

A recent study examining the effects of ketamine infusion on depression found that the infusion induces psychological experiences of awe. These experiences may mediate the effects of ketamine on the improvement of depression symptoms. The paper was published in Biological Psychiatry Global Open Science.

Willy Myco Just Released the First-Ever Video Demonstrating How to Synthesize LSD
5th January 2025 doubleblindmag.com | Humans, Misc.

The process for synthesizing Lysergic Acid Diethylamide (LSD), more commonly known as “acid,” has long been shrouded by complex chemistry jargon, not to mention laws discouraging anybody from posting the process online lest they incur serious legal consequences. As such, learning how to make LSD has long been a process known only to a select few. Until now, anyway.

When will MDMA be approved for therapy? Major trial issues may stand in the way, psychiatrist Dr. Albino Oliveira-Maia says.
18th December 2024 | livescience.com | Humans, Misc.

Psychedelics are being tested as add-ons to psychotherapy, but in trials, there’s little detail about how the therapy is actually conducted, Dr. Albino Oliveira-Maia says.

Miscellaneous news stories.